|
|
|
11-50 employees
View all
|
|
biotechnology
|
|
100 Acorn Park Drive,Cambridge,MA,US
|
|
Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS™, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.
|
Genocea Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
77.78%
|
The widely used Genocea email format is {first}.{last} (e.g. [email protected]) with 77.78% adoption across the company.
To contact Genocea customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.